PET-based radiomic analysis in multicentre lung cancer study and impact of feature domain harmonization.

Radiomic biomarkers have demonstrated significant potential in non-invasively assessing tumor biology and providing essential insights for precision medicine. However, the clinical translation is often hindered by challenges in multicenter studies, primarily due to a lack of standardization, such as variations in scanner models, acquisition protocols, reconstruction techniques, etc. This study aims to assess the impact of various harmonization methods in multicenter, 18 F-FDG PET-based radiomics for the classification of lung cancer histological subtypes using a machine learning model. Retrospective data included 178 lung cancer cohorts, comprising 117 adenocarcinomas and 61 squamous cell carcinomas from three different centers. PET DICOM image data was preprocessed with 3D ROI segmentation of the lung tumor and healthy liver, followed by the extraction of 111 radiomic features. Subsequently, Z-Score, Quantile, and ComBat were applied to generate three different harmonized datasets. Feature distribution was analyzed, and the top ten features were selected using recursive feature elimination. An eXtreme gradient boosting model was built on each dataset, and performance was assessed using accuracy, precision, sensitivity, specificity, and AUC with a 95% confidence interval. Variations in radiomic feature distribution and feature selection were observed after applying different harmonization methods. During validation of the trained model, AUC improved from 0.556 [95% CI 0.551-0.563] in the unharmonized data to 0.719 [95% CI 0.710-0.720], 0.952 [95% CI 0.951-0.954], and 0.996 [95% CI 0.995-0.996] in Z-Score, Quantile, and ComBat harmonized data, respectively, for classifying adenocarcinoma and squamous cell carcinoma subtypes. The study indicates that feature selection was affected by the different harmonization methods. The ComBat method was shown to significantly enhance the performance of AI-assisted PET radiomics.